ArticleTherapeutic advances in neurological disorders2021

Peginterferon beta-1a was associated with high adherence and satisfaction in patients with multiple sclerosis in a German real-world study.

Til Menge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.